Literature DB >> 11759979

Impact of liver cirrhosis on nutritional and immunological status.

A Sobhonslidsuk1, C Roongpisuthipong, K Nantiruj, S Kulapongse, S Songchitsomboon, K Sumalnop, N Bussagorn.   

Abstract

The aims of the study were to determine the prevalence of protein calorie malnutrition (PCM) in Thai cirrhotic patients and to evaluate nutritional and immunological status in various stages of cirrhosis. Subjective Global Assessment (SGA) and anthropometric measurement were used as nutritional assessment in sixty cirrhotic patients. Delayed-type hypersensitivity skin test, lymphocyte count, immunoglobulin and complement were assessed for immune status. Blood samples were sent for routine tests, prealbumin, thiamine and riboflavin level. There were 7/60 (11.7%) patients with percentage of ideal body weight (%IBW) less than 90 per cent. SGA, hemoglobin, protein indices and cholesterol level showed the deterioration of nutritional status in the late stage of the disease. Five (8.3%) patients with thiamine deficiency, and thirteen (21.7%) patients with riboflavine deficiency were detected. Lowest levels of complement and highest levels of immunoglobulin also occurred in the late stage of the disease. In conclusion, defining %IBW <90 per cent as malnutrition, the prevalence of malnutrition in Thai cirrhotic patients was 11.7 per cent. Nutritional and immunological status deteriorated according to the advanced stage of disease. If nutritional support is given in the early stage, it may improve nutritional status and reduce morbidity and mortality in cirrhotic patients.

Entities:  

Mesh:

Year:  2001        PMID: 11759979

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  10 in total

1.  Expression of growth hormone receptor and its mRNA in hepatic cirrhosis.

Authors:  Hong-Tao Wang; Shuang Chen; Jie Wang; Qing-Jia Ou; Chao Liu; Shu-Sen Zheng; Mei-Hai Deng; Xiao-Ping Liu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

2.  Expression of Fc Fragment Receptors of Immunoglobulin G (FcγRs) in Rat Hepatic Stellate Cells.

Authors:  Hong Shen; Manna Zhang; Kelly Kaita; Gerald Y Minuk; Julia Rempel; Yuewen Gong
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

Review 3.  Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score.

Authors:  Hee Yeon Kim; Jeong Won Jang
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 4.  Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses.

Authors:  Pranav Periyalwar; Srinivasan Dasarathy
Journal:  Clin Liver Dis       Date:  2012-01-23       Impact factor: 6.126

5.  Protective effects of recombinant human growth hormone on cirrhotic rats.

Authors:  Shuang Chen; Hong-Tao Wang; Bin Yang; Yu-Ru Fu; Qing-Jia Ou
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

6.  Anthropometric, biochemical and clinical assessment of malnutrition in Malaysian patients with advanced cirrhosis.

Authors:  Mei-Ling S Tai; Khean-Lee Goh; Siti Hawa Mohd-Taib; Sanjay Rampal; Sanjiv Mahadeva
Journal:  Nutr J       Date:  2010-06-24       Impact factor: 3.271

Review 7.  Clinical relevance of sarcopenia in patients with cirrhosis.

Authors:  Aldo J Montano-Loza
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

8.  A case of bacteremia by Neisseria gonorrhoeae coincident with massive hemorrhage of esophageal varices.

Authors:  Dahae Won; Dongheui An; Mi-Na Kim; Young Sang Lee
Journal:  Korean J Lab Med       Date:  2011-04

Review 9.  Nutrition assessment in patients undergoing liver transplant.

Authors:  Neha Bakshi; Kalyani Singh
Journal:  Indian J Crit Care Med       Date:  2014-10

10.  Different degrees of malnutrition and immunological alterations according to the aetiology of cirrhosis: a prospective and sequential study.

Authors:  Wanda Regina Caly; Edna Strauss; Flair José Carrilho; Antonio Atílio Laudanna
Journal:  Nutr J       Date:  2003-10-07       Impact factor: 3.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.